BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26934957)

  • 1. Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination.
    Kurashige J; Hasegawa T; Niida A; Sugimachi K; Deng N; Mima K; Uchi R; Sawada G; Takahashi Y; Eguchi H; Inomata M; Kitano S; Fukagawa T; Sasako M; Sasaki H; Sasaki S; Mori M; Yanagihara K; Baba H; Miyano S; Tan P; Mimori K
    Sci Rep; 2016 Mar; 6():22371. PubMed ID: 26934957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
    Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
    Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DDR2 Expression Is Associated with a High Frequency of Peritoneal Dissemination and Poor Prognosis in Colorectal Cancer.
    Sasaki S; Ueda M; Iguchi T; Kaneko M; Nakayama H; Watanabe T; Sakamoto A; Mimori K
    Anticancer Res; 2017 May; 37(5):2587-2591. PubMed ID: 28476831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-199a-3p promotes gastric cancer progression by promoting its stemness potential via DDR2 mediation.
    Ren L; Ren Q; Wang J; He Y; Deng H; Wang X; Liu C
    Cell Signal; 2023 Jun; 106():110636. PubMed ID: 36813149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
    Kiyozumi Y; Iwatsuki M; Kurashige J; Ogata Y; Yamashita K; Koga Y; Toihata T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Yanagihara K; Mimori K; Baba H
    Int J Cancer; 2018 Sep; 143(5):1202-1211. PubMed ID: 29603227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.
    Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K
    Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer.
    Hu Y; Qi C; Liu X; Zhang C; Gao J; Wu Y; Yang J; Zhao Q; Li J; Wang X; Shen L
    Cancer Lett; 2019 Aug; 457():142-150. PubMed ID: 31075288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer.
    Sako A; Kitayama J; Koyama H; Ueno H; Uchida H; Hamada H; Nagawa H
    Cancer Res; 2004 May; 64(10):3624-8. PubMed ID: 15150121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer.
    Miyake S; Kitajima Y; Nakamura J; Kai K; Yanagihara K; Tanaka T; Hiraki M; Miyazaki K; Noshiro H
    Int J Oncol; 2013 Nov; 43(5):1431-40. PubMed ID: 23970191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase-mitogen-activated protein kinases signaling pathway.
    Zou D; Song J; Deng M; Ma Y; Yang C; Liu J; Wang S; Wen Z; Tang Y; Qu X; Zhang Y
    FASEB J; 2021 May; 35(5):e21601. PubMed ID: 33913201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis.
    Grither WR; Divine LM; Meller EH; Wilke DJ; Desai RA; Loza AJ; Zhao P; Lohrey A; Longmore GD; Fuh KC
    Oncogene; 2018 Mar; 37(13):1714-1729. PubMed ID: 29348456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
    Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
    Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer.
    Kanda M; Shimizu D; Tanaka H; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
    Ann Surg; 2018 Mar; 267(3):495-503. PubMed ID: 28026832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer.
    Yoshikawa T; Yanoma S; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Miyagi Y; Morinaga S; Noguchi Y; Yamamoto Y
    Hepatogastroenterology; 2006; 53(72):964-7. PubMed ID: 17153464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel experimental mouse model of peritoneal dissemination of human gastric cancer cells: different mechanisms in peritoneal dissemination and hematogenous metastasis.
    Nishimori H; Yasoshima T; Denno R; Shishido T; Hata F; Okada Y; Ura H; Yamaguchi K; Isomura H; Sato N; Hirata K
    Jpn J Cancer Res; 2000 Jul; 91(7):715-22. PubMed ID: 10920279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites.
    Sakakura C; Hagiwara A; Nakanishi M; Shimomura K; Takagi T; Yasuoka R; Fujita Y; Abe T; Ichikawa Y; Takahashi S; Ishikawa T; Nishizuka I; Morita T; Shimada H; Okazaki Y; Hayashizaki Y; Yamagishi H
    Br J Cancer; 2002 Nov; 87(10):1153-61. PubMed ID: 12402156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain.
    Grither WR; Longmore GD
    Proc Natl Acad Sci U S A; 2018 Aug; 115(33):E7786-E7794. PubMed ID: 30061414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner.
    Hu L; Zang MD; Wang HX; Zhang BG; Wang ZQ; Fan ZY; Wu H; Li JF; Su LP; Yan M; Zhu ZQ; Yang QM; Huang Q; Liu BY; Zhu ZG
    Cell Death Dis; 2018 Feb; 9(3):278. PubMed ID: 29449539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin set out to ER stress signaling thwarts epithelial mesenchymal transition and peritoneal dissemination via calpain-mediated C/EBPβ and NFκB cleavage.
    Wu SM; Lin WY; Shen CC; Pan HC; Keh-Bin W; Chen YC; Jan YJ; Lai DW; Tang SC; Tien HR; Chiu CS; Tsai TC; Lai YL; Sheu ML
    J Pineal Res; 2016 Mar; 60(2):142-54. PubMed ID: 26514342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TIMP-1 gene transferred through adenovirus mediation shows a suppressive effect on peritoneal metastases from gastric cancer.
    Miyagi M; Aoyagi K; Kato S; Shirouzu K
    Int J Clin Oncol; 2007 Feb; 12(1):17-24. PubMed ID: 17380436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.